Stockscreener 앱 받기
136.77
3.72%
4.9718
Jazz Pharmaceuticals Plc 주식(JAZZ)의 최신 뉴스
Is Jazz Pharmaceuticals plc a candidate for recovery play2025 Performance Recap & Real-Time Buy Signal Alerts - newser.com
Will Jazz Pharmaceuticals plc stock rally after Fed decisionsJuly 2025 EndofMonth & Fast Exit and Entry Strategy Plans - newser.com
What MACD and RSI say about Jazz Pharmaceuticals plcShare Buyback & Consistent Growth Equity Picks - newser.com
Park Avenue Securities LLC Takes Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Will Jazz Pharmaceuticals plc (J7Z) stock remain on Wall Street radarMarket Growth Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Jazz Pharmaceuticals plc stock keep outperforming rivals2025 Key Highlights & Reliable Price Breakout Signals - newser.com
Will Jazz Pharmaceuticals plc (J7Z) stock announce special dividendOptions Play & Real-Time Volume Trigger Notifications - newser.com
Why Jazz Pharmaceuticals plc (J7Z) stock could be top winnerJuly 2025 Weekly Recap & Community Consensus Stock Picks - newser.com
Jazz Pharmaceuticals (JAZZ) Stock Analysis: 47% Potential Upside Catches Investor Attention - DirectorsTalk Interviews
Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 47% Upside Potential Beckons Investors - DirectorsTalk Interviews
State of Alaska Department of Revenue Boosts Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
What analysts say about Jazz Pharmaceuticals plc stockFederal Reserve Announcements & Small Investment Trading Tips - earlytimes.in
Jazz Pharmaceuticals plc J7Z Stock Analysis and ForecastTechnical Resistance Breaks & Low Cost Wealth Plans - earlytimes.in
What analysts say about Jazz Pharmaceuticals plc J7Z stockRSI Overbought/Oversold & Free Daily Stock Hotspot Analysis - earlytimes.in
Are Jazz Pharmaceuticals Shares Set for a Rebound After Recent Drug Approval in 2025? - simplywall.st
Piper Sandler Reaffirms Jazz Pharmaceuticals (JAZZ) Price Target Ahead of Trial Data - MSN
What drives Jazz Pharmaceuticals plc stock priceDividend Stock Watch & Exceptional Capital Investment - Early Times
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
EClinical Solutions Explores Data Intelligence in Modern Clinical Trials at ENGAGE 2025 - MarketScreener
JAZZ: Morgan Stanley Raises Price Target to $167, Maintains Over - GuruFocus
Affinity Wealth Management LLC Purchases New Position in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
United States Myelodysplastic Syndrome Treatment Market - openPR.com
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - MSN
Jazz Pharmaceuticals Secures Dismissal of Patent Fraud Lawsuit - Bloomberg Law News
Jazz Pharmaceuticals Announces Promising Xywav Data: Why I Assign A BUY Rating - Seeking Alpha
Here's Why JAZZ Stock Is an Unconventional Cannabis Investment - The Globe and Mail
Morgan Stanley Issues Positive Forecast for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Price - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Perpetual Ltd - MarketBeat
Jazz Pharmaceuticals PLC $JAZZ Shares Bought by CX Institutional - MarketBeat
Jazz Pharmaceuticals plc (JAZZ) Advances Rare Cancer Portfolio with First CNS Glioma Therapy Approval - Yahoo Finance
Jazz Pharmaceuticals stock price target raised to $167 from $163 at Morgan Stanley - Investing.com UK
Jazz Pharmaceuticals (JAZZ): Assessing Valuation Following Fresh Xywav Clinical Data at Leading Medical Conferences - simplywall.st
Wedmont Private Capital Decreases Stake in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals stock hits 52-week high of $134.24 - MSN
Swedbank AB Lowers Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz pharma presents new data on narcolepsy and hypersomnia treatment - Investing.com
Jazz Pharmaceuticals presents Xywav data at medical conferences - StreetInsider
Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses - PR Newswire
United States Narcolepsy Therapeutics Market Trends & Growth - openPR.com
Voya Investment Management LLC Acquires 22,628 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
How NCCN Endorsement of Modeyso May Shape Jazz Pharmaceuticals' (JAZZ) Rare Oncology Expansion - simplywall.st
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by MassMutual Private Wealth & Trust FSB - MarketBeat
2.76%
자본화:
|
볼륨(24시간):